Contrave/Mysimba

Naltrexone hydrochloride ER and Bupropion hydrochloride ER · Currax Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Contrave/Mysimba, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) [Phase 4]

See pricing